Citation 14733

IKEDA,T: TSUMAGARI,H: HONBU,T: NOHARA,T:. (2003). CYTOTOXIC ACTIVITY OF STEROIDAL GLYCOSIDES FROM SOLANUM PLANTS.. 26(8)

Citation Details

Title	CYTOTOXIC ACTIVITY OF STEROIDAL GLYCOSIDES FROM SOLANUM PLANTS.
Authors	IKEDA,T: TSUMAGARI,H: HONBU,T: NOHARA,T:
Year	2003
Volume	26
Issue	8

Summary

Year: 2003

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSCIN	ACTIVE
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DIOSCIN	ACTIVE
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLAMARGINE	ACTIVE
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLAMARGINE	ACTIVE
5	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLASONINE	INACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SOLASONINE	INACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-ENE,2-ALPHA-3-BETA-DIHYDROXY: 3-O-BETA-CHACOTRIOSIDE 25(S):	INACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROST-5-ENE,2-ALPHA-3-BETA-DIHYDROXY: 3-O-BETA-CHACOTRIOSIDE 25(S):	INACTIVE
9	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTANE,5-ALPHA: 3-BETA-6-ALPHA-DIHYDROXY: 3-O-ALPHA-L-RHAMNOPYRANSOYL(1-4)-BETA-D-GLUCOPYRANOSIDE 25(S):	INACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTANE,5-ALPHA: 3-BETA-6-ALPHA-DIHYDROXY: 3-O-ALPHA-L-RHAMNOPYRANSOYL(1-4)-BETA-D-GLUCOPYRANOSIDE 25(S):	INACTIVE
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTANE,5-BETA: 3-BETA-6-ALPHA-DIHYDROXY: 3-O-ALPHA-L-RHAMNOPYRANSOYL(1-4)-BETA-D-GLUCOPYRANOSIDE 25(S):	ACTIVE
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTANE,5-BETA: 3-BETA-6-ALPHA-DIHYDROXY: 3-O-ALPHA-L-RHAMNOPYRANSOYL(1-4)-BETA-D-GLUCOPYRANOSIDE 25(S):	INACTIVE
13	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGOGENIN-3-O-BETA-CHACOTRIOSIDE	ACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGOGENIN-3-O-BETA-CHACOTRIOSIDE	ACTIVE
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTANE,5-ALPHA: 2-ALPHA-3-BETA-DIHYDROXY: 3-O-BETA-CHACOTRISOIDE 25(S):	INACTIVE
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTANE,5-ALPHA: 2-ALPHA-3-BETA-DIHYDROXY: 3-O-BETA-CHACOTRISOIDE 25(S):	INACTIVE
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-17-ALPHA-DIHYDROXY: 3-O-BETA-D-XYLOPYANOSYL(1-3)-[ALPHA-L-ARABINOPYRANOSYL(1-2)]-BETA-D-GLUCOYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYANSOYL(1-2)]-BETA-D-GALACTOPYRANOSIDE 25(R):	INACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	SPIROSTAN-12-ONE,5-ALPHA: 3-BETA-17-ALPHA-DIHYDROXY: 3-O-BETA-D-XYLOPYANOSYL(1-3)-[ALPHA-L-ARABINOPYRANOSYL(1-2)]-BETA-D-GLUCOYRANOSYL(1-4)-[ALPHA-L-RHAMNOPYANSOYL(1-2)]-BETA-D-GALACTOPYRANOSIDE 25(R):	INACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGOGENIN-3-O-BETA-D-XYLOPYRANOSYL(1-3)-[ALPHA-L-ARABINOPYRNAOSYL(1-2)]-BETA-D-GLUCOPYRNAOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE	ACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGOGENIN-3-O-BETA-D-XYLOPYRANOSYL(1-3)-[ALPHA-L-ARABINOPYRNAOSYL(1-2)]-BETA-D-GLUCOPYRNAOSYL(1-4)-[ALPHA-L-RHAMNOPYRANOSYL(1-2)]-BETA-D-GALACTOPYRANOSIDE	ACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGOGENIN-3-O-BETA-D-GLUCOYRANOSYL(1-3)-[BETA-D-GLUCOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE	ACTIVE
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGOGENIN-3-O-BETA-D-GLUCOYRANOSYL(1-3)-[BETA-D-GLUCOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYRANOSIDE	ACTIVE
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGONIN,DEGALACTO:	ACTIVE
24	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGONIN,DEGALACTO:	ACTIVE
25	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGOGENIN,NEO: 3-O-LYCOTETRAOSIDE	ACTIVE
26	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIGOGENIN,NEO: 3-O-LYCOTETRAOSIDE	INACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTODIOSCIN	ACTIVE
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PROTODIOSCIN	ACTIVE
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTANE,5-BETA: 26-O-BETA-D-GLUCOPYRANOSYL-3-BETA-5-BETA-6-ALPHA-22-ALPHA-26-PENTAHYDROXY: 3-O-ALPHA-L-RHAMNOPYRANSOYL(1-4)-BETA-D-GLUCOPYANOSIDE 25(S):	INACTIVE
30	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTANE,5-BETA: 26-O-BETA-D-GLUCOPYRANOSYL-3-BETA-5-BETA-6-ALPHA-22-ALPHA-26-PENTAHYDROXY: 3-O-ALPHA-L-RHAMNOPYRANSOYL(1-4)-BETA-D-GLUCOPYANOSIDE 25(S):	INACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTANE,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-BETA-22-ALPHA-26-TRIHYDROXY: 3-O-BETA-CHACOTRIOSIDE 25(R):	INACTIVE
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTANE,5-ALPHA: 26-O-BETA-D-GLUCOPYRANOSYL-3-BETA-22-ALPHA-26-TRIHYDROXY: 3-O-BETA-CHACOTRIOSIDE 25(R):	INACTIVE
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIOGONIN,DEGALACTO:	ACTIVE
34	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TIOGONIN,DEGALACTO:	ACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTANE,5-ALPHA: 26-O-BETA-D-GLUCOPYRONOSYL-3-BETA-22-ALPHA-26-TRIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-[BETA-D-GLUCOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYANOSIDE 25-PHI:	ACTIVE
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	FUROSTANE,5-ALPHA: 26-O-BETA-D-GLUCOPYRONOSYL-3-BETA-22-ALPHA-26-TRIHYDROXY: 3-O-BETA-D-GLUCOPYRANOSYL(1-3)-[BETA-D-GLUCOPYRANOSYL(1-2)]-BETA-D-GLUCOPYRANOSYL(1-4)-BETA-D-GALACTOPYANOSIDE 25-PHI:	ACTIVE
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PREGNANE,5-ALPHA: 3-O-BETA-LYCOTETRAOSYL-3-BETA-16-BETA-20(S)-TRIHYDROXY: 16-O-(5-O-BETA-D-GLUCOPYRANOSYL-4(S)-METHYL-5-HYDROXY-PENTANOIC ACID) ESTER	INACTIVE
38	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PREGNANE,5-ALPHA: 3-O-BETA-LYCOTETRAOSYL-3-BETA-16-BETA-20(S)-TRIHYDROXY: 16-O-(5-O-BETA-D-GLUCOPYRANOSYL-4(S)-METHYL-5-HYDROXY-PENTANOIC ACID) ESTER	INACTIVE
39	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PREGNANE,3-O-ALPHA-L-RHAMNBOPYRANSOYL(1-4)-BETA-D-GLUCOPYRANSOYL-3-BETA-5-BETA-6-ALPHA-16-BETA-TETRAHYDROXY: 16-O-(5-O-BETA-GLUCOPYRANOSYL-4(S)-METHYL-5-HYDROXY-PENTANOIC ACID) ESTER	INACTIVE
40	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PREGNANE,3-O-ALPHA-L-RHAMNBOPYRANSOYL(1-4)-BETA-D-GLUCOPYRANSOYL-3-BETA-5-BETA-6-ALPHA-16-BETA-TETRAHYDROXY: 16-O-(5-O-BETA-GLUCOPYRANOSYL-4(S)-METHYL-5-HYDROXY-PENTANOIC ACID) ESTER	INACTIVE
41	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PREGNANE,5-ALPHA: 3-O-BETA-LYCOTETRAOSYL-3-BETA-16-DIHYDROXY: 20-CARBOXYLIC ACID-16-22-LACTONE	INACTIVE
42	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PREGNANE,5-ALPHA: 3-O-BETA-LYCOTETRAOSYL-3-BETA-16-DIHYDROXY: 20-CARBOXYLIC ACID-16-22-LACTONE	INACTIVE

Citation 14733

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1